Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nicotine-Specific Antibody (Anti-Nicotine Antibody)
- Target
- Anti-Nicotine Antibody
- Molecular classification
- Antibody, Immunoglobulin, IgG
01
Overview
Nicotine-specific antibodies are antibodies designed to bind and sequester nicotine in the bloodstream, preventing it from reaching its primary sites of action in the brain and peripheral tissues. These antibodies are generated through vaccination or administration of monoclonal antibodies and aim to reduce the pharmacological and addictive effects of nicotine.
- Other names
- Nicotine AntibodyAnti-Nicotine IgGNicotine-sequestering Antibody
02
Mechanism of action
Antibodies bind to nicotine in the bloodstream, preventing it from crossing the blood-brain barrier and reaching nicotinic acetylcholine receptors (nAChRs) in the brain.
03
Biological functions
Nicotine sequestrationNeutralization of nicotineImmune responseDrug clearance
04
Disease associations
Nicotine addictionSmoking cessationCardiovascular disease (related to nicotine use)
05
Safety considerations
Potential for off-target effectsImmunogenicity of carrier proteinAdverse reactions to adjuvantsEpitope Specificity
06
Interacting drugs
Nicotine
1 more in the full profile.
07
Biomarkers
Serum anti-nicotine IgG concentrationAntibody affinity for nicotine
Beyond the preview
Go deeper on Nicotine-Specific Antibody (Anti-Nicotine Antibody).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nicotine-Specific Antibody (Anti-Nicotine Antibody).